SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-026712
Filing Date
2024-02-07
Accepted
2024-02-07 16:20:02
Documents
15
Period of Report
2024-02-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d718313d8k.htm   iXBRL 8-K 38752
2 EX-99.1 d718313dex991.htm EX-99.1 10271
  Complete submission text file 0001193125-24-026712.txt   187394

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tern-20240206.xsd EX-101.SCH 2861
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tern-20240206_lab.xml EX-101.LAB 19499
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tern-20240206_pre.xml EX-101.PRE 12163
16 EXTRACTED XBRL INSTANCE DOCUMENT d718313d8k_htm.xml XML 3909
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 24604613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)